What happened
GeneOne Life Science updated the terms of a private placement (third-party allotment) to raise US$5.46M, about 16.7% of its market value.
For context, this raise equals about 16.7% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Private placement |
|---|---|
| Raise amount | US$5.46M |
| vs. market value | 16.7% |
| Filed | 2026-03-04, [Amended] Material event report (rights offering) |
| Source | DART rcept 20260304001422 → open original filing |
Source: DART. Information only, not investment advice.